Scientist dating website jade dating
Back at CSUN, he put the fossil under his microscope and made the startling discovery: unfossilized, undecayed tissue was present.If the dinosaur were 65 million years old, the soft tissue could not have possibly remained, he says.His findings seconded groundbreaking discoveries by noted molecular paleontologist Mary Schweitzer, who triggered an earthquake in the world of paleontology when she published about soft tissue in dinosaur bones in 2005.(Schweitzer subsequently postulated that iron is responsible for preserving the soft tissue.) Armitage’s February 2013 study was published in the peer-reviewed , a journal of cell and tissue research. A biology professor had come into his office and said, “We are not going to tolerate your religion in this department.” Armitage fought back.He engaged students in his lab with Socratic dialogue over the issue of the earth’s age based on his and others’ research, he said.
A graduate of Liberty University, Armitage adheres to the “young earth” view, against the majority of scientists who say our planet is 5 billion years old.
Alan Reinach, Armitage’s attorney, hailed the settlement as precedent-setting.
“We are not aware of any other cases where a creationist received a favorable outcome,” said Reinach, executive director of the Church State Council, a nonprofit California public interest legal organization.
“Today, the center, now affiliated with Magee Rehabilitation Hospital, is one of only 14 in the country to hold the federal government’s highest designation,” in ranking clinical outcomes, Jefferson said in its online tribute. Osterholm announced that he had developed a way to reverse stroke damage in mammals, under laboratory conditions, through a spinal perfusion of an oxygen-rich mixture, if done within three hours of the stroke. In 1984, he was honored as “Inventor of the Year” by the Intellectual Property Owners Association, a trade group for patent holders. Osterholm’s colleagues at Jefferson established the neurosurgery department’s first endowed chair in his name. He is a friend and mentor to me, and I am delighted to be able to follow in his footsteps.” Born in White Sulphur Springs, Mont., Dr. He earned a medical degree from Washington University School of Medicine in 1957, fully intending to become a cardiothoracic surgeon.
But by the late 1970s, his research emphasis shifted to the study of stroke and measures physicians could take to relieve the effects of insufficient blood flow to the brain and the reduced ability of brain tissue to use oxygen. The methodology progressed through early-phase clinical trials in humans, but foundered before the FDA. But during the last rotation of his final year in medical school, he rotated through the neurosurgery department.